Bcma antibodies and use of same to treat cancer and immunological disorders
US-2024109975-A1 · Apr 4, 2024 · US
This page is not indexed by search engines while we improve data quality.
Patent family 59562012
This patent family groups 8 related publications across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 59562012 |
| Family type | — |
| Earliest priority | Feb 17, 2016 |
| First filing country | US |
| Member publications | 8 |
| Countries | US |
| Representative publication | US2024109975A1 — Bcma antibodies and use of same to treat cancer and immunological disorders |
Representative publication
Best representative member for this family based on priority and filing country.
US2024109975A1 — Bcma antibodies and use of same to treat cancer and immunological disorders (published Apr 4, 2024)
Member publications
Related publications in this family.
BCMA antibodies and use of same to treat cancer and immunological disorders
US-11767365-B2 · Sep 26, 2023 · US
Bcma antibodies and use of same to treat cancer and immunological disorders
US-2022025062-A1 · Jan 27, 2022 · US
BCMA antibodies and use of same to treat cancer and immunological disorders
US-11078291-B2 · Aug 3, 2021 · US
Bcma antibodies and use of same to treat cancer and immunological disorders
US-2020002431-A1 · Jan 2, 2020 · US
Bcma antibodies and use of same to treat cancer and immunological disorders
US-2019194338-A1 · Jun 27, 2019 · US
Bcma antibodies and use of same to treat cancer and immunological disorders
US-2019023801-A1 · Jan 24, 2019 · US
Bcma antibodies and use of same to treat cancer and immunological disorders
US-2017233484-A1 · Aug 17, 2017 · US